HCA Healthcare vs Regeneron Pharmaceuticals

HCA Healthcare (HCA), health care, and Regeneron Pharmaceuticals (REGN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

HCA Healthcare is worth $105.3B on the stock market and Regeneron Pharmaceuticals $99.6B: HCA Healthcare is valued at 6% more. HCA Healthcare trades at 16.7 times earnings and Regeneron Pharmaceuticals at 21.3. Over the past year HCA Healthcare's share price has moved +7.04% and Regeneron Pharmaceuticals's +31.3%.

Key facts

HCA Healthcare market value
$105.3B
Regeneron Pharmaceuticals market value
$99.6B
HCA Healthcare P/E
16.7
Regeneron Pharmaceuticals P/E
21.3
HCA Healthcare revenue
$75.6BFY to 2025-12-31
Regeneron Pharmaceuticals revenue
$14.3BFY to 2025-12-31
Superinvestors holding both
2

Market values as of .

HCA Healthcare vs Regeneron Pharmaceuticals: every measure side by side
Measure HCA Healthcare Regeneron Pharmaceuticals
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$105.3Bhigher$99.6Blower
Revenue$75.6Bhigher$14.3Blower
Earnings$6.8Bhigher$4.5Blower
Employees230,000higher15,410lower
Total assets$60.7Bhigher$40.6Blower
Valuation
P/E16.7lower21.3higher
P/S1.4lower6.9higher
P/B—2.9
Dividend yield0.60%higher0.39%lower
Profitability
Operating margin—24.9%
Balance sheet
Net assets-$6Blower$31.3Bhigher
Total liabilities$63.5Bhigher$9.3Blower
Total debt$46.5Bhigher$2Blower
Cash on hand$1Blower$3.1Bhigher
Price change
Today-1.54%lower+1.06%higher
1 year+7.04%lower+31.3%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": HCA Healthcare / Regeneron Pharmaceuticals). Who owns HCA · Who owns REGN

Further comparisons

Learn

Questions and answers

Which is bigger, HCA Healthcare or Regeneron Pharmaceuticals?

By market value, HCA Healthcare is the larger: $105.3B against $99.6B for Regeneron Pharmaceuticals. By revenue in its latest fiscal year, HCA Healthcare is the larger: $75.6B against $14.3B for Regeneron Pharmaceuticals.

Which has the higher P/E ratio?

Regeneron Pharmaceuticals: 21.3, against 16.7 for HCA Healthcare. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher dividend yield?

HCA Healthcare: 0.60%, against 0.39% for Regeneron Pharmaceuticals. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

HCA Healthcare: $46.5B, against $2B for Regeneron Pharmaceuticals. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both HCA Healthcare and Regeneron Pharmaceuticals?

In their latest 13F filings, Josef Lakonishok and Ray Dalio (founder) hold both.

Cite this page

Funkfolio, “HCA Healthcare vs Regeneron Pharmaceuticals”, data as of 17 November 2026. https://funkfolio.com/compare/hca-vs-regn

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.